Literature DB >> 1567835

Steady-state kinetic mechanism of Ras farnesyl:protein transferase.

D L Pompliano1, E Rands, M D Schaber, S D Mosser, N J Anthony, J B Gibbs.   

Abstract

The steady-state kinetic mechanism of bovine brain farnesyl:protein transferase (FPTase) has been determined using a series of initial velocity studies, including both dead-end substrate and product inhibitor experiments. Reciprocal plots of the initial velocity data intersected on the 1/[s] axis, indicating that a ternary complex forms (sequential mechanism) and suggesting that the binding of one substrate does not affect the binding of the other. The order of substrate addition was probed by determining the patterns of dead-end substrate and product inhibition. Two nonhydrolyzable analogues of farnesyl diphosphate, (alpha-hydroxyfarnesyl)phosphonic acid (1) and [[(farnesylmethyl)hydroxyphosphinyl]methyl]phosphonic acid (2), were both shown to be competitive inhibitors of farnesyl diphosphate and noncompetitive inhibitors of Ras-CVLS. Four nonsubstrate tetrapeptides, CV[D-L]S, CVLS-NH2, N-acetyl-L-penicillamine-VIM, and CIFM, were all shown to be noncompetitive inhibitors of farnesyl diphosphate and competitive inhibitors of Ras-CVLS. These data are consistent with random order of substrate addition. Product inhibition patterns corroborated the results found with the dead-end substrate inhibitors. We conclude that bovine brain FPTase proceeds through a random order sequential mechanism. Determination of steady-state parameters for several physiological Ras-CaaX variants showed that amino acid changes affected the values of KM, but not those of kcat, suggesting that the catalytic efficiencies (kcat/KM) of Ras-CaaX substrates depend largely upon their relative binding affinity for FPTase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567835     DOI: 10.1021/bi00130a010

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Tomato Rab1A homologs as molecular tools for studying Rab geranylgeranyl transferase in plant cells.

Authors:  A E Loraine; S Yalovsky; S Fabry; W Gruissem
Journal:  Plant Physiol       Date:  1996-04       Impact factor: 8.340

2.  Cellular palmitoylation and trafficking of lipidated peptides.

Authors:  Jeremiah M Draper; Zuping Xia; Charles D Smith
Journal:  J Lipid Res       Date:  2007-05-24       Impact factor: 5.922

3.  Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.

Authors:  Thangaiah Subramanian; Suxia Liu; Jerry M Troutman; Douglas A Andres; H Peter Spielmann
Journal:  Chembiochem       Date:  2008-11-24       Impact factor: 3.164

4.  Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities.

Authors:  James L Hougland; Katherine A Hicks; Heather L Hartman; Rebekah A Kelly; Terry J Watt; Carol A Fierke
Journal:  J Mol Biol       Date:  2009-10-28       Impact factor: 5.469

5.  Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.

Authors:  Hong Jiang; Xiaoyu Zhang; Xiao Chen; Pornpun Aramsangtienchai; Zhen Tong; Hening Lin
Journal:  Chem Rev       Date:  2018-01-02       Impact factor: 60.622

6.  Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation.

Authors:  Nicola Ferri; Kohei Yokoyama; Martin Sadilek; Rodolfo Paoletti; Rafael Apitz-Castro; Michael H Gelb; Alberto Corsini
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

7.  Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton.

Authors:  G C Prendergast; J P Davide; S J deSolms; E A Giuliani; S L Graham; J B Gibbs; A Oliff; N E Kohl
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

8.  Synthesis and biological evaluation of a phosphonate analog of the natural acetyl cholinesterase inhibitor cyclophostin.

Authors:  Saibal Bandyopadhyay; Supratik Dutta; Christopher D Spilling; Cynthia M Dupureur; Nigam P Rath
Journal:  J Org Chem       Date:  2008-09-27       Impact factor: 4.354

Review 9.  Farnesyltransferase inhibitors and anti-Ras therapy.

Authors:  J B Gibbs; N E Kohl; K S Koblan; C A Omer; L Sepp-Lorenzino; N Rosen; N J Anthony; M W Conner; S J deSolms; T M Williams; S L Graham; G D Hartman; A Oliff
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Identification of Ras farnesyltransferase inhibitors by microbial screening.

Authors:  M Hara; K Akasaka; S Akinaga; M Okabe; H Nakano; R Gomez; D Wood; M Uh; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.